vs
Astrana Health, Inc.（ASTH）とCENTRAL GARDEN & PET CO（CENT）の財務データ比較。上の社名をクリックして会社を切り替えられます
Astrana Health, Inc.の直近四半期売上が大きい（$950.5M vs $617.4M、CENTRAL GARDEN & PET COの約1.5倍）。CENTRAL GARDEN & PET COの純利益率が高く（1.1% vs 0.7%、差は0.4%）。Astrana Health, Inc.の前年同期比売上増加率が高い（42.9% vs -6.0%）。Astrana Health, Inc.の直近四半期フリーキャッシュフローが多い（$-6.0M vs $-81.0M）。過去8四半期でAstrana Health, Inc.の売上複合成長率が高い（53.3% vs -17.2%）
アストラナヘルス社は米国に本拠を置く価値基準型医療サービスプロバイダーで、主に米国全土の連邦医療保険対象高齢者層にサービスを提供している。訪問型プライマリケア、慢性疾患管理、ケアコーディネーションを通じ、患者の健康状態改善と不要な医療費削減を目指している。
米国に本社を置くCentral Garden & Pet Coは、ペット用品と園芸製品の大手サプライヤーです。ペットフード、グルーミング用品、芝生管理グッズ、園芸アクセサリーなどを取り扱い、北米全域の量販店、個人経営のペットショップ、園芸センターなどに製品を供給しています。
ASTH vs CENT — 直接比較
損益計算書 — Q4 FY2025 vs Q1 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $950.5M | $617.4M |
| 純利益 | $6.6M | $6.8M |
| 粗利率 | — | 30.9% |
| 営業利益率 | 1.9% | 2.7% |
| 純利益率 | 0.7% | 1.1% |
| 売上前年比 | 42.9% | -6.0% |
| 純利益前年比 | 184.4% | -51.2% |
| EPS（希薄化後） | $0.12 | $0.11 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $950.5M | $617.4M | ||
| Q3 25 | $956.0M | $678.2M | ||
| Q2 25 | $654.8M | $960.9M | ||
| Q1 25 | $620.4M | $833.5M | ||
| Q4 24 | $665.2M | $656.4M | ||
| Q3 24 | $478.7M | $669.5M | ||
| Q2 24 | $486.3M | $996.3M | ||
| Q1 24 | $404.4M | $900.1M |
| Q4 25 | $6.6M | $6.8M | ||
| Q3 25 | $373.0K | $-9.8M | ||
| Q2 25 | $9.4M | $95.0M | ||
| Q1 25 | $6.7M | $63.6M | ||
| Q4 24 | $-7.8M | $14.0M | ||
| Q3 24 | $16.1M | $-34.2M | ||
| Q2 24 | $19.2M | $79.7M | ||
| Q1 24 | $14.8M | $62.0M |
| Q4 25 | — | 30.9% | ||
| Q3 25 | — | 29.0% | ||
| Q2 25 | — | 34.6% | ||
| Q1 25 | — | 32.8% | ||
| Q4 24 | — | 29.8% | ||
| Q3 24 | — | 25.2% | ||
| Q2 24 | — | 31.8% | ||
| Q1 24 | — | 31.0% |
| Q4 25 | 1.9% | 2.7% | ||
| Q3 25 | 2.0% | -0.9% | ||
| Q2 25 | 3.1% | 14.1% | ||
| Q1 25 | 3.3% | 11.2% | ||
| Q4 24 | 0.1% | 4.3% | ||
| Q3 24 | 5.9% | -4.8% | ||
| Q2 24 | 6.2% | 11.6% | ||
| Q1 24 | 7.5% | 10.4% |
| Q4 25 | 0.7% | 1.1% | ||
| Q3 25 | 0.0% | -1.4% | ||
| Q2 25 | 1.4% | 9.9% | ||
| Q1 25 | 1.1% | 7.6% | ||
| Q4 24 | -1.2% | 2.1% | ||
| Q3 24 | 3.4% | -5.1% | ||
| Q2 24 | 3.9% | 8.0% | ||
| Q1 24 | 3.7% | 6.9% |
| Q4 25 | $0.12 | $0.11 | ||
| Q3 25 | $0.01 | $-0.16 | ||
| Q2 25 | $0.19 | $1.52 | ||
| Q1 25 | $0.14 | $0.98 | ||
| Q4 24 | $-0.14 | $0.21 | ||
| Q3 24 | $0.33 | $-0.51 | ||
| Q2 24 | $0.40 | $1.19 | ||
| Q1 24 | $0.31 | $0.93 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $429.5M | $721.1M |
| 総負債低いほど良い | — | $1.2B |
| 株主資本純資産 | $779.3M | $1.6B |
| 総資産 | $2.2B | $3.6B |
| 負債/資本比率低いほどレバレッジが低い | — | 0.76× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $429.5M | $721.1M | ||
| Q3 25 | $463.4M | $882.5M | ||
| Q2 25 | $342.1M | $713.0M | ||
| Q1 25 | $260.9M | $516.7M | ||
| Q4 24 | $290.8M | $618.0M | ||
| Q3 24 | $350.3M | $753.5M | ||
| Q2 24 | $327.7M | $570.4M | ||
| Q1 24 | $337.3M | $301.3M |
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | — | $1.2B |
| Q4 25 | $779.3M | $1.6B | ||
| Q3 25 | $775.5M | $1.6B | ||
| Q2 25 | $765.5M | $1.6B | ||
| Q1 25 | $745.4M | $1.5B | ||
| Q4 24 | $712.7M | $1.5B | ||
| Q3 24 | $704.6M | $1.6B | ||
| Q2 24 | $678.9M | $1.6B | ||
| Q1 24 | $653.5M | $1.5B |
| Q4 25 | $2.2B | $3.6B | ||
| Q3 25 | $2.2B | $3.6B | ||
| Q2 25 | $1.4B | $3.7B | ||
| Q1 25 | $1.3B | $3.6B | ||
| Q4 24 | $1.4B | $3.5B | ||
| Q3 24 | $1.3B | $3.6B | ||
| Q2 24 | $1.3B | $3.6B | ||
| Q1 24 | $1.2B | $3.5B |
| Q4 25 | — | 0.76× | ||
| Q3 25 | — | 0.75× | ||
| Q2 25 | — | 0.75× | ||
| Q1 25 | — | 0.77× | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | 0.76× | ||
| Q2 24 | — | 0.75× | ||
| Q1 24 | — | 0.79× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $-2.9M | $-70.2M |
| フリーキャッシュフロー営業CF - 設備投資 | $-6.0M | $-81.0M |
| FCFマージンFCF / 売上 | -0.6% | -13.1% |
| 設備投資強度設備投資 / 売上 | 0.3% | 1.8% |
| キャッシュ転換率営業CF / 純利益 | -0.44× | -10.26× |
| 直近12ヶ月FCF直近4四半期 | $104.5M | $285.0M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $-2.9M | $-70.2M | ||
| Q3 25 | $10.0M | $182.7M | ||
| Q2 25 | $90.9M | $265.5M | ||
| Q1 25 | $16.6M | $-46.9M | ||
| Q4 24 | $-10.9M | $-68.8M | ||
| Q3 24 | $34.0M | $203.1M | ||
| Q2 24 | $23.2M | $286.1M | ||
| Q1 24 | $6.0M | $-24.5M |
| Q4 25 | $-6.0M | $-81.0M | ||
| Q3 25 | $7.4M | $171.9M | ||
| Q2 25 | $89.5M | $251.7M | ||
| Q1 25 | $13.6M | $-57.5M | ||
| Q4 24 | $-13.5M | $-74.9M | ||
| Q3 24 | $31.7M | $193.0M | ||
| Q2 24 | $20.4M | $272.5M | ||
| Q1 24 | $5.6M | $-33.9M |
| Q4 25 | -0.6% | -13.1% | ||
| Q3 25 | 0.8% | 25.3% | ||
| Q2 25 | 13.7% | 26.2% | ||
| Q1 25 | 2.2% | -6.9% | ||
| Q4 24 | -2.0% | -11.4% | ||
| Q3 24 | 6.6% | 28.8% | ||
| Q2 24 | 4.2% | 27.3% | ||
| Q1 24 | 1.4% | -3.8% |
| Q4 25 | 0.3% | 1.8% | ||
| Q3 25 | 0.3% | 1.6% | ||
| Q2 25 | 0.2% | 1.4% | ||
| Q1 25 | 0.5% | 1.3% | ||
| Q4 24 | 0.4% | 0.9% | ||
| Q3 24 | 0.5% | 1.5% | ||
| Q2 24 | 0.6% | 1.4% | ||
| Q1 24 | 0.1% | 1.0% |
| Q4 25 | -0.44× | -10.26× | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | 2.79× | ||
| Q1 25 | 2.48× | -0.74× | ||
| Q4 24 | — | -4.91× | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 1.21× | 3.59× | ||
| Q1 24 | 0.40× | -0.40× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
CENT
| Garden Products Segment | $201.6M | 33% |
| Dogand Cat Products | $157.0M | 25% |
| Other Pet Products | $117.8M | 19% |
| Manufactured Product Other | $102.5M | 17% |
| Wild Bird Products | $38.5M | 6% |
